Discontinued — last reported Q1 '23
Products & Services · Benefits and Expenses
Critical Care — Benefits and Expenses
Aflac Critical Care — Benefits and Expenses increased by 2.9% to $11.82B in Q1 2023 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ4 2022
Last reportedQ1 2023May 1, 2023
How to read this metric
A lower ratio of benefits and expenses relative to revenue indicates higher underwriting efficiency and better profitability for the segment.
Detailed definition
This metric aggregates all costs directly associated with the Critical Care insurance segment, including policyholder be...
Peer comparison
Equivalent to 'Segment Operating Expenses and Benefits' or 'Underwriting Costs' reported by peer insurance companies.
Metric ID:
afl_segment_critical_care_benefits_and_expensesHistorical Data
2 periods
| Q4 '22 | Q1 '23 | |
|---|---|---|
| Value | $11.49B | $11.82B |
| QoQ Change | — | +2.9% |
Range$11.49B – $11.82B
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Aflac's critical care — benefits and expenses?
- Aflac (AFL) reported critical care — benefits and expenses of $11.82B in Q1 2023.
- What does critical care — benefits and expenses mean?
- The total costs incurred by the Critical Care segment to pay claims and manage the business.